Fueling Technology

Innovation in Healthcare

Doppler Bio is building a reprogrammable ADAR sensor platform to detect disease-associated RNAs and produce engineered proteins to manipulate cell states without permanent genome editing.

Resilience is changing the way complex medicines are made and distributed by leveraging technology innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.

Relation deploys active-graph machine learning (ML) combined with single-cell analysis to advance therapeutic candidates for diseases with no or few good medicines.

Paradigm is rebuilding the clinical research ecosystem by creating a platform which enables equitable access to trials for all patients, while enhancing trial efficiency.

Deep Genomics uses artificial intelligence and machine learning to rapidly accelerate drug discovery and development for rare genetic and chronic diseases.